Holly Hoefer is the Vice President of Marketing and Patient Engagement with Helios Clinical Research. Holly’s tenure within the biotech industry began in 2001, serving in various leadership roles within Fortune 500 companies.  Her work has been strategically focused in the areas of health literacy, marketing, health economics and patient recruitment.    Utilizing the latest in patient recruitment techniques, coupled with cutting edge technology and ICD10 data, Holly has successfully planned and recruited patients for clinical trials in various therapeutic areas and phases, with a primary focus in oncology, infectious disease, bariatrics, and vaccines.  

Holly draws from her years of experience in patient-centric engagement, to design and brand trials, while educating patients in innovative ways.  Her focus is always ‘engineered engagement’ to promote randomization into clinical trials that achieve either on time, or early enrollment.  Holly’s work is notable within a high-profile clientele and touts a successful track record designing outreach for recruiting FIH - Ph. 4 studies.   

Holly holds a Masters degree in Heath Communications from Boston University and a CPC-H in hospital billing and coding with a strong background in health economics.  Holly is also GCP certified.